Form D · Private Equity Fund
BXLS V - Edison - 8xx, L.P.
New York, NY · CIK 0001813697
Offering snapshot reported Jun 1, 2020 · SEC filing
- Reported sold
- Yet to sell Indefinite offering
- Investors reported
- 0 Form D · investor count
- Minimum accepted
- $0 Reported outside-investor minimum
- First sale
- Yet to occur As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Jun 1, 2020 | Initial | Yet to sell | No comparison | 0 | SEC filing |
Offering details
- Securities
- Pooled investment fund
- Exemptions
- 06b, 3C, 3C.7
- Duration over one year
- No
- Business combination
- No
- Sales commissions
- $0
- Finders' fees
- $0
- Form D file number
- 021-368026
Source: Form D, filed Jun 1, 2020. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| N/A Blackstone Life Sciences Associates V (Cym) L.L.C. | Promoter |
| Olivier Brandicourt | Director |
| Julie Constable | Director |
| Chaim Miller | Director |
| David Payne | Director |
| Omar Rehman | Director |
| William Young | Director |
Issuer details
Industry: Pooled Investment Fund (See others in industry)
Address:
345 Park Avenue
New York, NY, 10154
New York, NY, 10154